System, Test, Tumor Marker, Monitoring, Bladder
Main Filters
System, Test, Tumor Marker, Monitoring, Bladder
| Alere Scarborough, Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| D1200 | 0 | - | ||
| D1200 | 0 | - | ||
| D1250 | 0 | - | ||
| D1250 | 0 | - | ||
| D1300 | 0 | - | ||
| NUCLEIX LTD | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| NX899090-01-US | 0 | - | ||
| NX899090-02US | 0 | - | ||
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 661010 | 0 | - | ||
| 661203 | 0 | - | ||
| 661210 | 0 | - | ||
| 661230 | 0 | - | ||
| 661505 | 0 | - | ||
| 661510 | 0 | - | ||
| 662150 | 0 | - | ||
| 662160 | 0 | - | ||
| PRINCETON BIOMEDITECH CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| BSP-307-10-00 | 0 | - | ||
| BSP-307-25-00 | 0 | - | ||
17 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Status BTA Card
PRINCETON BIOMEDITECH CORPORATION
Status BTA (CLIA Waived); 10 Test Kit
0
-
Status BTA Card
PRINCETON BIOMEDITECH CORPORATION
Status BTA (CLIA Waived); 25 Test Kit
0
-
BTA stat
POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC
BTA stat - Controls - US Labeled15 Deteriminations
0
-
BTA stat
POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC
BTA stat Test - 10 Test kit - Internationally Labeled
0
-
BTA stat
POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC
BTA stat Test - 10 Test kit - Hitado Labeled
0
-
Alere NMP22 BladderChek Test
Alere Scarborough, Inc.
The Alere NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.
0
-
Alere NMP22 BladderChek Control Kit
Alere Scarborough, Inc.
The Alere NMP22 BladderChek Control Kit consists of a Negative and a Positive Control solution for use as an external control for the Alere NMP22 BladderChek Test.
0
-
Alere NMP22 BladderChek Test
Alere Scarborough, Inc.
The Alere NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.
0
-
NMP22 BladderChek Control Kit
Alere Scarborough, Inc.
NMP22 BladderChek Control Kit consists of a Negative and a Positive Control solution for use as an external control for the NMP22 BladderChek Test.
0
-
NMP22 BladderChek Test
Alere Scarborough, Inc.
NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.